Cargando…

Reducing the Kidney Uptake of High Contrast CXCR4 PET Imaging Agents via Linker Modifications

Purpose: The C-X-C chemokine receptor 4 (CXCR4) is highly expressed in many subtypes of cancers, notably in several kidney-based malignancies. We synthesized, labeled, and assessed a series of radiotracers based on a previous high contrast PET imaging radiopharmaceutical [(68)Ga]Ga-BL02, with modifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwon, Daniel, Zhang, Zhengxing, Zeisler, Jutta, Kuo, Hsiou-Ting, Lin, Kuo-Shyan, Benard, Francois
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316317/ https://www.ncbi.nlm.nih.gov/pubmed/35890397 http://dx.doi.org/10.3390/pharmaceutics14071502

Ejemplares similares

(68)Ga-Labeled [Thz(14)]Bombesin(7–14) Analogs: Promising GRPR-Targeting Agonist PET Tracers with Low Pancreas Uptake
por: Wang, Lei, et al.
Publicado: (2023)

Evaluation of Met-Val-Lys as a Renal Brush Border Enzyme-Cleavable Linker to Reduce Kidney Uptake of (68)Ga-Labeled DOTA-Conjugated Peptides and Peptidomimetics
por: Bendre, Shreya, et al.
Publicado: (2020)

(68)Ga-Labeled [Leu(13)ψThz(14)]Bombesin(7–14) Derivatives: Promising GRPR-Targeting PET Tracers with Low Pancreas Uptake
por: Wang, Lei, et al.
Publicado: (2022)

Positron Emission Tomography Imaging of the Gastrin-Releasing Peptide Receptor with a Novel Bombesin Analogue
por: Lau, Joseph, et al.
Publicado: (2019)

Novel (68)Ga-Labeled Pyridine-Based Fibroblast Activation Protein-Targeted Tracers with High Tumor-to-Background Contrast
por: Verena, Arsyangela, et al.
Publicado: (2023)

Selective Cyclized α-Melanocyte-Stimulating Hormone Derivative with Multiple N-Methylations for Melanoma Imaging with Positron Emission Tomography
por: Zhang, Chengcheng, et al.
Publicado: (2020)

Monosodium Glutamate Reduces (68)Ga-PSMA-11 Uptake in Salivary Glands and Kidneys in a Preclinical Prostate Cancer Model
por: Rousseau, Etienne, et al.
Publicado: (2018)

Synthesis and Evaluation of (68)Ga-Labeled (2S,4S)-4-Fluoropyrrolidine-2-Carbonitrile and (4R)-Thiazolidine-4-Carbonitrile Derivatives as Novel Fibroblast Activation Protein-Targeted PET Tracers for Cancer Imaging
por: Bendre, Shreya, et al.
Publicado: (2023)

Synthesis and Preclinical Evaluation of Three Novel (68)Ga-Labeled Bispecific PSMA/FAP-Targeting Tracers for Prostate Cancer Imaging
por: Verena, Arsyangela, et al.
Publicado: (2023)

What a difference a methylene makes: replacing Glu with Asp or Aad in the Lys-urea-Glu pharmacophore of PSMA-targeting radioligands to reduce kidney and salivary gland uptake
por: Kuo, Hsiou-Ting, et al.
Publicado: (2022)

Lys-urea-Aad, Lys-urea-Cmc and Lys-urea-Cms as potential pharmacophores for the design of PSMA-targeted radioligands to reduce off-target uptake in kidneys and salivary glands
por: Kuo, Hsiou-Ting, et al.
Publicado: (2023)

Synthesis and Preclinical Evaluation of Novel (68)Ga-Labeled (R)-Pyrrolidin-2-yl-boronic Acid-Based PET Tracers for Fibroblast Activation Protein-Targeted Cancer Imaging
por: Bendre, Shreya, et al.
Publicado: (2023)

Synthesis and Evaluation of (99m)Tc-Labeled PSMA-Targeted Tracers Based on the Lys-Urea-Aad Pharmacophore for Detecting Prostate Cancer with Single Photon Emission Computed Tomography
por: Lu, Kelly, et al.
Publicado: (2023)

(18)F-Labeled Cyclized α-Melanocyte-Stimulating Hormone Derivatives for Imaging Human Melanoma Xenograft with Positron Emission Tomography
por: Zhang, Chengcheng, et al.
Publicado: (2019)

Application of Cleavable Linkers to Improve Therapeutic Index of Radioligand Therapies
por: Lau, Joseph, et al.
Publicado: (2022)

Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands
por: Kwon, Daniel, et al.
Publicado: (2022)

Design, synthesis and evaluation of (18)F-labeled cationic carbonic anhydrase IX inhibitors for PET imaging
por: Zhang, Zhengxing, et al.
Publicado: (2017)

Insight into the Development of PET Radiopharmaceuticals for Oncology
por: Lau, Joseph, et al.
Publicado: (2020)

Preclinical Melanoma Imaging with (68)Ga-Labeled α-Melanocyte-Stimulating Hormone Derivatives Using PET
por: Zhang, Chengcheng, et al.
Publicado: (2017)

Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX
por: Lau, Joseph, et al.
Publicado: (2017)

A Systematic Review of Molecular Imaging Agents Targeting Bradykinin B1 and B2 Receptors
por: Lau, Joseph, et al.
Publicado: (2020)

One-Step (18)F-Labeling and Preclinical Evaluation of Prostate-Specific Membrane Antigen Trifluoroborate Probes for Cancer Imaging
por: Kuo, Hsiou-Ting, et al.
Publicado: (2019)

Evaluation of agonist and antagonist radioligands for somatostatin receptor imaging of breast cancer using positron emission tomography
por: Dude, Iulia, et al.
Publicado: (2017)

Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor
por: Zhang, Chengcheng, et al.
Publicado: (2017)

Improving the stability of (11)C–labeled L-methionine with ascorbate
por: Woods, Michael, et al.
Publicado: (2017)

Dendrimer-based contrast agents for PET imaging
por: Zhao, Lingzhou, et al.
Publicado: (2017)

Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK
por: Trachsel, Belinda, et al.
Publicado: (2023)

Synthesis of DOTA-pyridine chelates for (64)Cu coordination and radiolabeling of αMSH peptide
por: Yang, Hua, et al.
Publicado: (2021)

New imaging agents targeting chemokine receptor CXCR4 for PET/SPECT and MRI
por: Poty, Sophie, et al.
Publicado: (2014)

Combination of PET and CXCR4-Targeted Peptide Molecule Agents for Noninvasive Tumor Monitoring
por: Lin, Yizi, et al.
Publicado: (2019)

Dependence of Chromatosome Structure on Linker Histone Sequence and Posttranslational Modification
por: Öztürk, Mehmet Ali, et al.
Publicado: (2018)

Variability in contrast agent uptake by different but similar stem cell types
por: Ketkar-Atre, Ashwini, et al.
Publicado: (2013)

First (18)F-Labeled Pentixafor-Based Imaging Agent for PET Imaging of CXCR4 Expression In Vivo
por: Poschenrieder, Andreas, et al.
Publicado: (2016)

Proteomic Analysis of Iodinated Contrast Agent-Induced Perturbation of Thyroid Iodide Uptake
por: Hichri, Maha, et al.
Publicado: (2020)

Quantitative evaluation of contrast agent uptake in standard fat‐suppressed dynamic contrast‐enhanced MRI examinations of the breast
por: Kousi, Evanthia, et al.
Publicado: (2017)

Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imaging
por: Mitchell, Nick, et al.
Publicado: (2013)

Inhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation
por: Ngamsri, Kristian-Christos, et al.
Publicado: (2020)

8-Hydroxyquinoline Glycoconjugates: Modifications in the Linker Structure and Their Effect on the Cytotoxicity of the Obtained Compounds
por: Krawczyk, Monika, et al.
Publicado: (2019)

Impact of Linker Modification and PEGylation of Vancomycin Conjugates on Structure-Activity Relationships and Pharmacokinetics
por: Umstätter, Florian, et al.
Publicado: (2022)

Post-Translation Modifications and Mutations of Human Linker Histone Subtypes: Their Manifestation in Disease
por: Kumar, Ashok, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pbg95gpqmoe49j4kl2s8cn23kt